ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA01 | G | Imatinib - 100mg | 7296 | 187475/13 | SAGITTA | 100mg | 60 | Capsule, hard | Oral | Raymond Georges Abou Adal & Co | Adamed Pharma S.A., Pabianice, Poland, for Arwan Pharmaceutical industries Lebanon SAL | Lebanon | 25,170,264 L.L | 19.35 | D | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA01 | B | Imatinib (mesylate) - 100mg | 4041 | 24542/07 | GLIVEC | 100mg | 60 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Produktions GmbH, Wehr | Germany | 46,549,228 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 100mg | 7884 | 149914/1 | APO-IMATINIB | 100mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 38,330,537 L.L | 19.35 | D | Apotex Inc | Canada | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 100mg | 7396 | 166542/11 | CEMIVIL | 100mg | 30 | Tablet, film coated | Oral | Abela Frères S.A.L. | The Arab Pharmaceutical Manufacturing PSC | Jordan | 16,466,387 L.L | 19.35 | D | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
L01EA01 | G | Imatinib (mesylate) - 100mg | 7491 | 185822/13 | GLIMATINIB BENTA | 100mg | 60 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 17,619,185 L.L | 19.35 | D | 2/5/2024 | 0 | ||
L01EA01 | G | Imatinib (mesylate) - 100mg | 7308 | 185821/13 | GLIMATINIB BENTA | 100mg | 120 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 43,103,200 L.L | 10.71 | E1 | 2/5/2024 | 0 | ||
L01EA01 | G | Imatinib - 100mg | 10951 | 23222/1 | IMATINIB GP PHARM | 100mg | 180 | Tablet, coated | Oral | Mediterranean Pharmaceutical Company | GP-Pharm, SA | Argentine | 26,083,945 L.L | 19.35 | D | GP-Pharm, SA | Argentine | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 100mg | 10957 | 90722/1 | IMATINIB NEAPOLIS | 100mg | 60 | Tablet, film coated | Oral | Medis Pharm Drugstore | Neapolis Pharma | Tunisia | 31,085,276 L.L | 19.35 | D | Neapolis Pharma | Tunisia | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 100mg | 10958 | 90822/1 | IMATINIB NEAPOLIS | 100mg | 30 | Tablet, film coated | Oral | Medis Pharm Drugstore | Neapolis Pharma | Tunisia | 16,360,672 L.L | 19.35 | D | Neapolis Pharma | Tunisia | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 100mg | 11265 | 6621/1 | IMATINIB SPC | 100mg | 60 | Tablet, film coated | Oral | Advanced Healthcare Services SAL | Pharmaline SAL Licensed by Sudair Pharma Company, KSA | Lebanon | 29,473,181 L.L | 19.35 | D | 2/5/2024 | 0 |